Report grades hospitals on predatory patient billing practices
RevCycle Intelligence
June 16, 2021
Drug Channels: The 340B Program Soared to $38 Billion in 2020—Up 27% vs. 2019
Despite what you may have heard, the 340B Drug Pricing Program continues to thrive.